AdJane Unveils Mucosal Booster Strategy for Next-Generation Respiratory Vaccine Franchises
AdJane unveils a mucosal booster strategy for next-generation respiratory vaccine franchises using its nOMV platform technology.
AdJane
Private
clinical-stage vaccine platform company for pandemic preparedness, global health and antimicrobial-resistance applications; native outer membrane vesicle (nOMV) technology for antigen presentation, self-adjuvanting vaccines, mucosal/intramuscular routes, multivalent/broad-spectrum design, scalable OMV manufacturing and selective partnering